D-0304-2021 Class II Ongoing
FDA drug recall D-0304-2021 was initiated by Bryant Ranch Prepack, Inc. Dba BRP Pharmaceuticals on Jan 27, 2021 and is designated Class II. Reason for recall: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets. The recall status is ongoing. Affected quantity: 12 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 24, 2021
- Initiation Date
- Jan 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 bottles
Product description
Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01
Reason for recall
Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 148992, Exp 5/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0304-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026